Connors Investor Services’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-30,538
| Closed | -$214K | – | 153 |
|
|
2022
Q2 | $214K | Sell |
30,538
-5,000
| -14% | -$35K | 0.03% | 133 |
|
|
2022
Q1 | $295K | Sell |
35,538
-9,000
| -20% | -$74.7K | 0.03% | 128 |
|
|
2021
Q4 | $302K | Sell |
44,538
-15,000
| -25% | -$102K | 0.03% | 126 |
|
|
2021
Q3 | $316K | Hold |
59,538
| – | – | 0.03% | 127 |
|
|
2021
Q2 | $342K | Hold |
59,538
| – | – | 0.04% | 122 |
|
|
2021
Q1 | $274K | Hold |
59,538
| – | – | 0.03% | 131 |
|
|
2020
Q4 | $199K | Buy |
59,538
+18,000
| +43% | +$60.2K | 0.02% | 136 |
|
|
2020
Q3 | $123K | Buy |
+41,538
| New | +$123K | 0.02% | 130 |
|